Skip to main content

Table 1 Comparison between the two studied groups according to clinical manifestations

From: Role of annexin A2 and osteopontin for early diagnosis of hepatocellular carcinoma in hepatitis C virus patients

Clinical manifestations Group A (n = 40) Group B (n = 40) χ 2 P
No. % No. %
Anorexia 21 52.5 38 95.0 18.660* < 0.001*
Fatigue 24 60.0 36 90.0 9.600* 0.002*
Abdominal pain 20 50.0 20 50.0 0.000 1.000
Fever 6 15.0 8 20.0 0.346 0.556
Change in the color of urine and eyes 2 5.0 2 5.0 0.000 FEp = 1.000
Dyspepsia 25 62.5 38 95.0 12.624* < 0.001*
Vomiting 6 15.0 2 5.0 2.222 FEp = 0.263
Weight loss 4 10.0 10 25.0 3.117 0.077
Cachexia 4 10.0 17 42.5 10.912* 0.001*
Jaundice 2 5.0 2 5.0 0.000 FEp = 1.000
Splenomegaly 16 40.0 20 50.0 0.808 0.369
Hepatomegaly 9 22.5 8 20.0 0.075 0.785
  1. FE Fisher Exact
  2. χ2 Chi square test
  3. p p value for comparing between the studied groups
  4. *Statistically significant at p ≤ 0.05